Panakeia

Developing rapid instrument-free diagnostic technologies to reduce the need for multiple lab-based tests.

Problem

Currently, a cancer diagnosis is an iterative, multi-step process requiring analysis of a tissue biopsy by a pathologist, followed by several lab-based tests (molecular and genetic). These lab-based tests account for 90% of the time and cost associated with diagnosis and contribute to 44% of pathology delays.

Solution

Panakeia’s software can provide pathologists with all the information needed for diagnosis and treatment from initial biopsies – eliminating the need for lab tests.

Team

• Dr. Pahini Pandya – CEO & Co-Founder
• Pandu Raharja-Liu – CTO & Co-Founder

Website and social media

• Link
• LinkedIn
• Twitter

UN Sustainable Development Goals